Author: Im, Kyungtaek; Kim, Jisu; Min, Hyeyoung
Title: Ginseng, the natural effectual antiviral: Protective effects of Korean Red Ginseng against viral infection Document date: 2015_9_16
ID: u800148j_2
Snippet: Recent progress in the formulation of antiviral therapies and vaccines has helped to prevent, shorten the duration, or decrease the severity of viral infection [5e7] . Most antiviral agents are designed to target viral components, but mutations in the viral genome often result in drug resistance and immune evasion, creating a major hurdle for antiviral therapies and vaccine development [8] . In addition, the continuous emergence of new infectious.....
Document: Recent progress in the formulation of antiviral therapies and vaccines has helped to prevent, shorten the duration, or decrease the severity of viral infection [5e7] . Most antiviral agents are designed to target viral components, but mutations in the viral genome often result in drug resistance and immune evasion, creating a major hurdle for antiviral therapies and vaccine development [8] . In addition, the continuous emergence of new infectious agents such as the Ebola virus and Middle East respiratory syndrome coronavirus (MERS-CoV) necessitate the advancement of novel therapeutic approaches. Accordingly, great attention has recently been drawn to the development of antivirals with broadspectrum efficacy and immunomodulators which improve host resilience by increasing host resistance to the viral infection [9] .
Search related documents:
Co phrase search for related documents- infectious agent and prevent help: 1
- infectious agent and recent progress: 1, 2
- infectious agent and therapeutic approach: 1
- infectious agent and vaccine antiviral therapy: 1
- infectious agent and vaccine development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- infectious agent and viral component: 1
- infectious agent and viral genome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- infectious agent and viral infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30
- major hurdle and recent progress: 1
- major hurdle and vaccine development: 1, 2, 3
- major hurdle and viral genome: 1, 2
- novel therapeutic approach and therapeutic approach: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- novel therapeutic approach and vaccine development: 1, 2, 3
- novel therapeutic approach and viral genome: 1, 2
- novel therapeutic approach and viral infection: 1, 2
- prevent help and recent progress: 1
- prevent help and vaccine development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- prevent help and viral genome: 1
- prevent help and viral infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
Co phrase search for related documents, hyperlinks ordered by date